Dow Up 1.31% Nasdaq Up 2.40%

Medivation, Inc. (MDVN)

-NasdaqGS
96.97 1.99(2.10%) Oct 21, 4:00PM EDT
Prev Close:94.98
Open:95.86
Bid:60.00 x 1000
Ask:N/A
1y Target Est:107.39
Beta:-0.64
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:95.65 - 98.09
52wk Range:53.65 - 103.88
Volume:1,106,778
Avg Vol (3m):1,159,360
Market Cap:7.45B
P/E (ttm):311.80
EPS (ttm):0.31
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
MDVNUp 2.10%7.45B
ABT63.74B
DNDN170.97M
JNJ283.04B

Key Statistics

Forward P/E (1 yr):28.11
P/S (ttm):18.61
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :2.43
Quarterly EPS Est (Sep-14) :0.82
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Medivation, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies to treat serious diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback